Skip to main content

Table 2 PDI, zeta potential, saturation solubility, and drug content results

From: An impact of nanocrystals on dissolution rate of Lercanidipine: Supersaturation and crystallization by addition of solvent to antisolvent

Batch

PDI

Saturation Solubility(μg/ml)

Zeta potential(mv)

% Drug content

CCD1

0.13 ± 0.05

88.95 ± 2.01

27.70 ± 2.78

81.27 ± 1.64

CCD2

0.21 ± 0.03

89.53 ± 3.14

26.91 ± 1.73

80.47 ± 2.15

CCD3

0.26 ± 0.01

85.62 ± 2.12

25.06 ± 2.39

86.22 ± 2.04

CCD4

0.19 ± 0.01

85.38 ± 2.89

30.38 ± 1.15

94.56 ± 2.20

CCD5

0.18 ± 0.01

88.08 ± 2.56

27.29 ± 1.32

92.51 ± 1.98

CCD6

0.26 ± 0.03

84.44 ± 2.96

29.59 ± 1.37

91.71 ± 2.40

CCD7

0.19 ± 0.01

89.91 ± 2.58

25.66 ± 2.54

93.07 ± 1.98

CCD8

0.12 ± 0.02

91.79 ± 2.62

27.18 ± 1.34

93.14 ± 2.40

CCD9

0.15 ± 0.01

80.59 ± 2.17

27.89 ± 1.32

90.65 ± 1.91

LER NCs

0.20 ± 0.34

87.78 ± 3.27

28.69 ± 1.56

93.15 ± 2.24

LER

3.35 ± 0.33

6.03 ± 0.65

3.51 ± 0.62